It is necessary to conduct in vitro and in vivo experiments, as well as analyze clinical data to confirm the inhibition and treatment of bladder cancer by has-miR-150 and CASC1 in the future. The gene discussed is DNAI7; the disease is urinary bladder carcinoma.